The filing

Disclosure pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Changes in Senior Management Personnel.

Company

Piramal Pharma Ltd · BSE 543635

Filed

30 September 2026, 17:55 IST

BSE category

Company Update / Change in Management

Tag

Change in Management · selected

Source

Open the filing on BSE →

Why it led

• First Change in Management from this company — not seen in the 97 trading days on record
• Mid cap · NIFTY 500
• 2 filings today

Selected by the ranker from 40 filings that day. Each line above is a component of that score, not a comment on the filing.

How often this tag appears

2,695 of 90,682 filings in the published window carry Change in Management · 2.97%

Around it

Also filed by Piramal Pharma Ltd on 30 September 2026

• Change in Management Change in Management20:08 IST
• Clarification sought from Piramal Pharma Ltd Clarification17:53 IST

Most recent filings from Piramal Pharma Ltd

• Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Expiry And Non-Renewal Of Commercial Arrangement With Bayer Pharmaceuticals Private Limited General1 October 2026 · 20:10 IST
• 543635 - Clarification On News Item Which Appeared In The 'Www.Thehindubusinessline.Com' Dated September 30, 2026 Captioned 'Ontario Contributes $1.7 Million Investment To Advance Life Sciences Innovation At Piramal Pharma'S Aurora Facility.' General1 October 2026 · 19:03 IST
• Change in Management Change in Management30 September 2026 · 20:08 IST